Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

22nd Century Group Inc (XXII)

22nd Century Group Inc (XXII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,405
  • Shares Outstanding, K 506
  • Annual Sales, $ 24,380 K
  • Annual Income, $ -15,160 K
  • EBIT $ -12 M
  • EBITDA $ -11 M
  • 60-Month Beta 1.78
  • Price/Sales 0.11
  • Price/Cash Flow N/A
  • Price/Book 0.17

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 122.79%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 0.00% on 07/14/25
  • IV Low 0.00% on 07/14/25
  • Put/Call Vol Ratio 0.00
  • Today's Volume 20
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 3,022
  • Open Int (30-Day) 3,011

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.24 +8.02%
on 07/16/25
13.80 -66.81%
on 06/17/25
-9.68 (-67.88%)
since 06/16/25
3-Month
4.24 +8.02%
on 07/16/25
32.66 -85.98%
on 05/05/25
-12.85 (-73.72%)
since 04/16/25
52-Week
4.24 +8.02%
on 07/16/25
2,837.04 -99.84%
on 07/17/24
-2,696.77 (-99.83%)
since 07/16/24

Most Recent Stories

More News
VLN Commercial Launches Confirm Viability of the FDA’s Proposed Reduced Nicotine Mandate

Multiple Tobacco Brands Partnering with 22nd Century to Expand Availability and Awareness of VLN Based Reduced Nicotine Content Products  Manufactured in the USA, VLN Products from 22nd Century Provide...

XXII : 4.58 (-3.58%)
22nd Century Provides Corporate Update On Its VLN® MRTP Renewal Process – The First and Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less

XXII : 4.58 (-3.58%)
22nd Century Announces Operation 100 – A 100mm VLN® Cigarette Designed to Reach Even More Adult Smokers Who Want to Reduce Their Nicotine Consumption

XXII : 4.58 (-3.58%)
22nd Century Announces Second Partner VLN Product Deal as Part of Major Pinnacle Brand Expansion Agreement with Top-5 C-Store Chain

XXII : 4.58 (-3.58%)
Emerging Growth Research Releases Q1 2025 Update Report on 22nd Century Group

New York, New York--(Newsfile Corp. - May 21, 2025) - Emerging Growth Research today released its latest quarterly update report on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q1 2025...

XXII : 4.58 (-3.58%)
22nd Century to Present at the Emerging Growth Conference on May 21, 2025

XXII : 4.58 (-3.58%)
22nd Century: Q1 Earnings Snapshot

22nd Century: Q1 Earnings Snapshot

XXII : 4.58 (-3.58%)
22nd Century Group Reports First Quarter 2025 Financial Results

XXII : 4.58 (-3.58%)
22nd Century Group Completes Sale of Needle Rock Farms Assets

XXII : 4.58 (-3.58%)
22nd Century Group Further Reduces Debt by $1.0 Million Following Financing Transaction

XXII : 4.58 (-3.58%)

Business Summary

22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products...

See More

Key Turning Points

3rd Resistance Point 5.27
2nd Resistance Point 4.99
1st Resistance Point 4.79
Last Price 4.58
1st Support Level 4.31
2nd Support Level 4.03
3rd Support Level 3.83

See More

52-Week High 2,837.04
Fibonacci 61.8% 1,754.91
Fibonacci 50% 1,420.64
Fibonacci 38.2% 1,086.37
Last Price 4.58
52-Week Low 4.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar